Delayed Graft Function Terminated Phase 2 Trials for Eculizumab (DB01257)

Also known as: Graft Function, Delayed

IndicationStatusPhase
DBCOND0004880 (Delayed Graft Function)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01919346Eculizumab for Prevention of Delayed Graft Function (DGF) in Kidney TransplantationPrevention